Latest news
Please click on the headings below to be directed to the stories:
Charity Golf Day near Swansea raises £2,500 for Myeloma UK
Myeloma UK fundraiser and supporter David Rose held a Charity Golf Day at Pennard Golf Club, near Swansea, on Friday 23 July to raise funds and awareness of myeloma.
Long-term myeloma survival triples since 1970s
People diagnosed with myeloma today are three times more likely to live for at least another 10 years compared to those diagnosed in the 1970s.
Be part of a unique cricket event at Lord’s
Myeloma UK, Bunbury Cricket Club and Lord’s have teamed up for a one-off event on Sunday 5 September 2010.
A unique opportunity to spend a day at Lord’s, to play or to watch a match on the Nursery Ground in the morning, have lunch with faces from the sport and entertainment world and then watch a Twenty20 match between the world’s number one charity cricket team and Joe Kinnear’s team of football celebrities in the afternoon.
The day’s cricket will be overseen by Chris Cowdrey, former England cricket captain.
National Myeloma Awareness Week 2010 a great success
Thank you for your help in making National Myeloma Awareness Week 2010 an enormous success.
Hundreds of people across the UK joined forces during 21-28 June to raise awareness of myeloma. We are delighted with how the week went and extend a big thank you to all of our supporters.
British 10K London Run 11 July 2010
Congratulations and thanks go out to all our amazing runners who took part in the 2010 British 10K London Run. Whilst the funds are still coming in we expect our 20 runners to have raised an impressive £20,000 – funds raised will go towards helping Myeloma UK to continue to provide information and support to patients, carers and family members affected by myeloma and to fund important research.
Mile for Myeloma Month
The first Mile for Myeloma was a great success. People loved it. This year’s Mile for Myeloma Month in May encouraged Myeloma UK supporters to take part in any activity involving a mile.
Retail Therapy Walk for Research in London raises over £40,000
Over 200 Myeloma UK supporters took part in the Retail Therapy Walk for Research on Sunday 13 June. The day was a great success, raising in excess of £40,000 for research into finding new, effective treatments for myeloma, and money is still coming in.
New nasal spray for breakthrough cancer pain is approved for use in Wales
The All Wales Medicines Strategy Group (AWMSG) has approved Instanyl™ (fentanyl) for use in Wales to help cancer patients manage episodes of breakthrough pain. Instanyl is a new intranasal formulation of fentanyl which is already commonly used as a patch, lollipop or tablet.
NICE gives draft approval to Thalidomide™ and Velcade™ as initial treatment options
The National Institute for Health and Clinical Excellence (NICE) has issued a draft approval for the use of Thalidomide Pharmion™ (thalidomide) and Velcade™ (bortezomib) combinations by newly-diagnosed myeloma patients.
Velcade™ is approved as initial treatment option in Wales
The All Wales Medicines Strategy Group (AWMSG) has approved Velcade™ (bortezomib) for use in Wales in newly diagnosed myeloma patients who are not eligible for a stem cell transplant.
Edinburgh Marathon, Team Relay & Scottish Half Marathon
Congratulations and thanks go out to all our amazing runners who took part in both the Edinburgh Marathon and the Scottish Half Marathon.
Myeloma leads the way in five-year cancer survival increases
Recent data from the Office for National Statistics show that five-year survival rates in myeloma are increasing at one of the fastest paces among all cancer types.
Revlimid™ approved for use in Scotland
Today the Scottish Medicines Consortium (SMC) has recommended the myeloma drug, Revlimid (lenalidomide) for use in Scotland. Myeloma UK welcomes the decision which means all myeloma patients across the UK now have access to this important drug.
Virgin London Marathon 25 April 2010
Congratulations and thanks go out to all our amazing runners who took part in the 2010 Virgin London Marathon. Whilst the funds are still coming in we expect our 30 runners to have raised an impressive £54,000.
Promising new myeloma drug goes to next stage of study
An international myeloma trial of a promising new drug, vorinostat, has been given the green light to continue by an independent Data Safety and Monitoring Board.
The Milly Apthorp Charitable Trust awards £300,000 to Myeloma UK for two key projects
Myeloma UK has been awarded its largest grant to date from a charitable trust.
The Milly Apthorp Charitable Trust has awarded Myeloma UK a total of £300,000 to be spent over the next two-three years, including £190,000 for the Myeloma UK Early Phase Clinical Trial Network and £110,000 for a project called “Pass Mark”.